search
Back to results

Bowel Preparation in Elective Pediatric Colorectal Surgery

Primary Purpose

Colostomy, Hirschsprung Disease - Pull Through, Necrotizing Enterocolitis

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Senna
Sodium Picosulfate, Magnesium Oxide and Citric Acid
Metronidazole Oral
Neomycin
Cefazolin
Metronidazole
Nil per os
Clear fluids the day before surgery
Sponsored by
McMaster University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Colostomy

Eligibility Criteria

3 Months - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Pediatric patients aged three months to eighteen years being treated by the Pediatric General Surgery service at McMaster Children's Hospital.
  2. Undergoing elective colorectal surgery.
  3. Parents or legal guardian able to give free and informed consent.

Exclusion Criteria:

  1. Non-elective surgery
  2. Procedures that would not require mechanical bowel preparation:

    1. Colorectal resection with an existing diverting small bowel ostomy.
    2. Completion proctectomy - Ileal Pouch Anal Anasotmosis (IPAA)
    3. Closure of small bowel ostomy (e.g. ileostomy)
  3. Mechanical bowel obstruction
  4. Known hypersensitivity to laxatives or oral antibiotics (neomycin and metronidazole)
  5. Contraindication to oral antibiotics
  6. Patients on long-term antibiotics for other reasons
  7. Congestive heart failure
  8. Renal insufficiency
  9. Other medical conditions precluding the use of either oral antibiotics or mechanical bowel preparation
  10. Co-enrolment in another intervention trial

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Active Comparator

    Placebo Comparator

    Arm Label

    Combination bowel prep

    Oral antibiotics

    No prep

    Arm Description

    Patients will received mechanical bowel preparation (age appropriate dose, starting 2 days before surgery) and prophylactic oral antibiotics (3 doses, 1 day before surgery). Clear fluids (or breast milk if applicable) will be given starting day before surgery. The standard care will also be delivered (NPO for anesthesia and intravenous antibiotics on induction) Patients/parents will be provided with stool diary to document the adequacy of preparation. This will include frequency and character of stool according to Bristol grade. The treating surgeon will rate the adequacy of the preparation intra-operatively.

    The patients will receive prophylactic oral antibiotics (3 doses, 1 day before surgery)as well as standard care (NPO for anesthesia and intravenous antibiotics on induction).

    Patients will receive no pre-operative bowel prep. The will receive the standard care only.

    Outcomes

    Primary Outcome Measures

    Feasibility (no. enrolled)
    recruitment rate (percentage of eligible patients enrolled and retained to the end of study).
    rate of post-randomization exclusions
    Patients excluded after being randomized
    Protocol deviations
    Number of protocol deviations
    Adverse events
    Any expected and unexpected adverse event, with grade of adverse event
    Incomplete follow-up
    Number missing follow-up appointments at 2 week mark

    Secondary Outcome Measures

    Superficial Incisional surgical site infection (SSI)
    Rate of SI-SSI (superficial or deep, number of patients who developed SSI per group/subgroup).
    Deep incisional surgical site infection (SSI)
    Rate of DI-SSI (number of patients who developed SSI per group/subgroup).
    Organ space - Surgical site infection (SSI)
    Rate of OS- SSI (number of patients who developed OS-SSI per group/subgroup).
    Anastomotic leak - Surgical site infection (SSI)
    Rate of anastomotic leak (verified by a contrast study or intra-operatively) (number of patients who developed OS-SSI per group/subgroup).
    Length of hospital stay
    Post-operative hospitalization on primary admission in days
    Time to full enteric feed.
    Post-operative return to full feed/diet in days
    Re-admission
    admission in post-operative period for a reason related to the surgery (yes/No)
    Re-operation
    Yes/No. Note:operation indication is directly related to the surgery
    Electrolyte disturbance
    significant changes in electrolytes (abnormal levels) (Yes/No)
    Electrolyte disturbance
    If abnormal levels were detected, whether this was associate by clinical signs (Yes/No)
    Clostridium difficile infection
    Occurrence of C. difficile infection post-operatively (Yes/No)

    Full Information

    First Posted
    May 22, 2018
    Last Updated
    November 25, 2021
    Sponsor
    McMaster University
    Collaborators
    McMaster Pediatric Surgery Rresearch Collaborative (MPSRC)
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03593252
    Brief Title
    Bowel Preparation in Elective Pediatric Colorectal Surgery
    Official Title
    Pre-Operative Mechanical Bowel Preparation And Prophylactic Oral Antibiotics For Pediatric Patients Undergoing Elective Colorectal Surgery: A Feasibility Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2021
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    January 1, 2022 (Anticipated)
    Primary Completion Date
    January 30, 2024 (Anticipated)
    Study Completion Date
    January 30, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    McMaster University
    Collaborators
    McMaster Pediatric Surgery Rresearch Collaborative (MPSRC)

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Infections after elective intestinal surgery remain a significant burden for patients and for the health care system. The cost of treating a single surgical site infection is estimated at approximately $27,000. In adult patients, there is good evidence that the combination of oral antibiotics and mechanical bowel preparation is effective at reducing infections after intestinal surgery. In children, the body of evidence is much weaker. In this population, little evidence exists for oral antibiotics reducing infections and no data exists as to the effect of combining antibiotics with mechanical bowel preparation (such as polyethylene glycol (PEG)). The goal of the proposed study is to examine the effects of oral antibiotics with and without the combined use of mechanical bowel preparation on the rate of post-operative infectious complications in children aged 6 months to 18 years. This will be compared to the institution's current standard of care, which is to abstain from any type of mechanical bowel preparations or oral antibiotic administration before intestinal surgery.
    Detailed Description
    Background: A Cochrane review of randomized controlled trials of MBP use in adults showed no difference in the rate of wound infection or anastomotic leak in colon or rectal procedures with MBP compared to no preparation (Guenaga, Matos, & Wille-Jorgensen, 2011). Two recent systematic reviews and meta-analyses support those findings. Lok and colleagues (2018) identified two randomized controlled trials and four retrospective reviews for patient <21 years, looking at preoperative MBP and its effect on the incidence postoperative complications, including anastomotic leak, wound infection, and intra-abdominal infection (Janssen Lok M 2018). Overall, MBP before colorectal surgery did not significantly decrease the incidence of post-operative outcomes. This was consistent with findings from a systematic review in mechanical bowel preparation in pediatric population. The review showed that the risk of developing a post-operative infection was 10.1% in patients who received MBP compared to 9.1% in patients who did not receive MBP, resulting in no statistically significant difference difference (risk difference of -0.03% (95% CI, -0.09% - 0.03%)) (Zwart 2018). With regards to OA alone, the adult literature showed promising results in favour of the OA. In a Cochrane review on antimicrobial prophylaxis in colorectal surgery, the addition of OA to the intravenous antibiotics was found to reduce surgical wound infection (RR 0.56, 95% CI 0.43 to 0.74) (Nelson, Gladman, & Barbateskovic, 2014). There are fewer studies in the pediatric population on the subject, they contain fewer patients and are mainly retrospective in nature. In a multi-center retrospective study, Serrurier et al. (2012), reviewed outcomes in children who underwent colostomy closure, and found higher rates of wound infection (14% vs. 6%, p=0.04) and a longer hospital length of stay in children who received MBP. In a retrospective cohort study including 1581 pediatric patients from PHIS database, post-operative complications were found to be highest in the no preparation group compared to combination prep and OA alone (23.3%, 15.9%, and 14.2% respectively; p=0.002) (Ares 2018). One study compared MBP alone versus MBP with OA in children undergoing colostomy closure post anorectal malformation repair and found no difference in overall SSI rates (MBP+OA: 13% (7/53) versus MBP alone: 17% (7/12) p=0.64) (Breckler, Rescorla, & Billmire, 2010). The authors found that the use of MBP alone was associated with a greater risk of wound infection (14% vs. 6%, p=0.04) and a longer hospital stay. Evidence to support the sole use of oral antibiotics versus in combination with MBP is lacking, particularly in the pediatric literature, with more studies being required to address this question. One recent meta-analysis including adults assessed 8458 adult patients (38 clinical trials), comparing 4 groups of different bowel preparation: MBP with OA, OA only, MBP only, and no preparation. The primary outcome was the total rate of incisional and organ/space SSIs. Results showed that only MBP with OA versus MBP alone was associated with a statistically significant reduction in SSI rates. The use of OA without MBP was not associated with a statistically significant reduction in SSI rates when compared to any other group. The authors concluded that MBP with OA was associated with the lowest risk of SSI, followed by OA only (Toh et al., 2018). It remains unclear whether the addition of MBP to OA in pediatric population affects the rate of post-operative infectious complications positively or negatively. The current study is therefore needed to build on the work conducted in the adult literature to determine best practices for the pediatric population. Purpose: This is a pilot study to check the feasibility of conducting a randomized controlled trial to assess the efficacy of oral nonabsorbable antibiotics, with or without mechanical bowel preparation, in reducing the rate of post-operative infectious complications occurring within 30 days post-operatively in children and adolescents (aged 6 months to 18 years) undergoing elective colon or rectal surgery. Post-operative complications include: surgical site infections (incisional, organ-space, and anatomic leak), length of hospital stay, readmission, post-operative use of therapeutic antibiotics, re-operation, occurrence of electrolyte disturbances (in case MBP was used), and occurrence of C. difficile infection.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Colostomy, Hirschsprung Disease - Pull Through, Necrotizing Enterocolitis, Inflammatory Bowel Diseases, Meconium Ileus, Bowel Obstruction, Elective Surgery

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Patients will be randomized to the following study arms: Combination bowel prep: Mechanical preparation and oral non-absorbable antibiotics + standard care. Oral antibiotics + standard care. No preparation, with standard care. *Standard care (all groups): Nil per os (NPO) prior to general anesthesia Solids until 8 hours prior to surgery, formula until 6 hours, breast milk until 4 hours, clear fluids until 2 hours Prophylactic IV antibiotics Cefazolin (30mg/kg) and metronidazole (15mg/kg) within 60 minutes of incision Re-dosing if procedure exceeds 4 hours In case of beta-lactam allergy allergy, clindamycin 5mg/kg and gentamicin 7mg/kg will be used.
    Masking
    Outcomes Assessor
    Masking Description
    The patient's records will mention he/she is part of a study and will mention the study number, while the actual medications received (group allocation) will not be mentioned. The outcome detector, assessing the patient from day 1 in the hospital to the end of the study, will not have access to information on the study group allocation. The statistician analyzing the data will have a coded and de-identified version, and will be blinded to study groups to ensure unbiased analysis. For the purpose of blinding the data analyst, data on bowel prep diary will be withheld until analysis for all other outcomes is done and finalized. The principle investigators and the research coordinator will be involved in prescribing the prep regimen preoperatively and will not be blinded. The patient and family will be aware of the medications used and will not be blinded either. Also, the pharmacist will have access to the treatment allocation list, and cannot be blinded.
    Allocation
    Randomized
    Enrollment
    81 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Combination bowel prep
    Arm Type
    Experimental
    Arm Description
    Patients will received mechanical bowel preparation (age appropriate dose, starting 2 days before surgery) and prophylactic oral antibiotics (3 doses, 1 day before surgery). Clear fluids (or breast milk if applicable) will be given starting day before surgery. The standard care will also be delivered (NPO for anesthesia and intravenous antibiotics on induction) Patients/parents will be provided with stool diary to document the adequacy of preparation. This will include frequency and character of stool according to Bristol grade. The treating surgeon will rate the adequacy of the preparation intra-operatively.
    Arm Title
    Oral antibiotics
    Arm Type
    Active Comparator
    Arm Description
    The patients will receive prophylactic oral antibiotics (3 doses, 1 day before surgery)as well as standard care (NPO for anesthesia and intravenous antibiotics on induction).
    Arm Title
    No prep
    Arm Type
    Placebo Comparator
    Arm Description
    Patients will receive no pre-operative bowel prep. The will receive the standard care only.
    Intervention Type
    Drug
    Intervention Name(s)
    Senna
    Other Intervention Name(s)
    Senokot
    Intervention Description
    Laxative,used for bowel preparation
    Intervention Type
    Drug
    Intervention Name(s)
    Sodium Picosulfate, Magnesium Oxide and Citric Acid
    Other Intervention Name(s)
    Pico-Salax
    Intervention Description
    Laxative used for bowel preparation
    Intervention Type
    Drug
    Intervention Name(s)
    Metronidazole Oral
    Other Intervention Name(s)
    flagyl
    Intervention Description
    Oral antibiotic
    Intervention Type
    Drug
    Intervention Name(s)
    Neomycin
    Intervention Description
    Oral non-absorbable antibiotic
    Intervention Type
    Drug
    Intervention Name(s)
    Cefazolin
    Other Intervention Name(s)
    ancef
    Intervention Description
    Intravenous antibiotic to be given on anesthesia induction and prior to incision as a prophylactic antibiotic.
    Intervention Type
    Drug
    Intervention Name(s)
    Metronidazole
    Other Intervention Name(s)
    Flagyl
    Intervention Description
    Intravenous antibiotic to be given on anesthesia induction and prior to incision as prophylactic antibiotic.
    Intervention Type
    Other
    Intervention Name(s)
    Nil per os
    Other Intervention Name(s)
    NPO
    Intervention Description
    Fasting orders according to anesthesia prior to surgery: No solid for >=8 hours, no formula milk/full liquids >= 4hours; no breast milk or clear fluids >=2hours.
    Intervention Type
    Other
    Intervention Name(s)
    Clear fluids the day before surgery
    Intervention Description
    As part of bowel preparation, participants will be asked to stick to clear fluids following breakfast the day before surgery. Breast milk is allowed if applicable.
    Primary Outcome Measure Information:
    Title
    Feasibility (no. enrolled)
    Description
    recruitment rate (percentage of eligible patients enrolled and retained to the end of study).
    Time Frame
    From randomization to 30 days post-operatively
    Title
    rate of post-randomization exclusions
    Description
    Patients excluded after being randomized
    Time Frame
    From randomization to 30 days post-operatively
    Title
    Protocol deviations
    Description
    Number of protocol deviations
    Time Frame
    From randomization to 30 days post-operatively
    Title
    Adverse events
    Description
    Any expected and unexpected adverse event, with grade of adverse event
    Time Frame
    From randomization to 30 days post-operatively
    Title
    Incomplete follow-up
    Description
    Number missing follow-up appointments at 2 week mark
    Time Frame
    From randomization to 30 days post-operatively
    Secondary Outcome Measure Information:
    Title
    Superficial Incisional surgical site infection (SSI)
    Description
    Rate of SI-SSI (superficial or deep, number of patients who developed SSI per group/subgroup).
    Time Frame
    30 days post-operatively.
    Title
    Deep incisional surgical site infection (SSI)
    Description
    Rate of DI-SSI (number of patients who developed SSI per group/subgroup).
    Time Frame
    30 days post-operatively.
    Title
    Organ space - Surgical site infection (SSI)
    Description
    Rate of OS- SSI (number of patients who developed OS-SSI per group/subgroup).
    Time Frame
    30 days post-operatively.
    Title
    Anastomotic leak - Surgical site infection (SSI)
    Description
    Rate of anastomotic leak (verified by a contrast study or intra-operatively) (number of patients who developed OS-SSI per group/subgroup).
    Time Frame
    30 days post-operatively.
    Title
    Length of hospital stay
    Description
    Post-operative hospitalization on primary admission in days
    Time Frame
    30 days post-operatively.
    Title
    Time to full enteric feed.
    Description
    Post-operative return to full feed/diet in days
    Time Frame
    30 days post-operatively.
    Title
    Re-admission
    Description
    admission in post-operative period for a reason related to the surgery (yes/No)
    Time Frame
    30 days post-operatively.
    Title
    Re-operation
    Description
    Yes/No. Note:operation indication is directly related to the surgery
    Time Frame
    30 days post-operatively.
    Title
    Electrolyte disturbance
    Description
    significant changes in electrolytes (abnormal levels) (Yes/No)
    Time Frame
    On day of surgery
    Title
    Electrolyte disturbance
    Description
    If abnormal levels were detected, whether this was associate by clinical signs (Yes/No)
    Time Frame
    On day of surgery
    Title
    Clostridium difficile infection
    Description
    Occurrence of C. difficile infection post-operatively (Yes/No)
    Time Frame
    30 days post-operatively.

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    3 Months
    Maximum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Pediatric patients aged three months to eighteen years being treated by the Pediatric General Surgery service at McMaster Children's Hospital. Undergoing elective colorectal surgery. Parents or legal guardian able to give free and informed consent. Exclusion Criteria: Non-elective surgery Procedures that would not require mechanical bowel preparation: Colorectal resection with an existing diverting small bowel ostomy. Completion proctectomy - Ileal Pouch Anal Anasotmosis (IPAA) Closure of small bowel ostomy (e.g. ileostomy) Mechanical bowel obstruction Known hypersensitivity to laxatives or oral antibiotics (neomycin and metronidazole) Contraindication to oral antibiotics Patients on long-term antibiotics for other reasons Congestive heart failure Renal insufficiency Other medical conditions precluding the use of either oral antibiotics or mechanical bowel preparation Co-enrolment in another intervention trial
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Daniel Briatico, MSc
    Phone
    905-521-2100
    Ext
    76692
    Email
    briaticd@mcmaster.ca
    First Name & Middle Initial & Last Name or Official Title & Degree
    Lisa VanHouwelingen, MD, MPH, FRCSC
    Email
    vanhoul@mcmaster.ca
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Lisa VanHouwelingen, MD, MPH, FRCSC
    Organizational Affiliation
    McMaster Children's Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    20638534
    Citation
    Breckler FD, Rescorla FJ, Billmire DF. Wound infection after colostomy closure for imperforate anus in children: utility of preoperative oral antibiotics. J Pediatr Surg. 2010 Jul;45(7):1509-13. doi: 10.1016/j.jpedsurg.2009.10.054. Erratum In: J Pediatr Surg. 2010 Nov;45(11):2292.
    Results Reference
    background
    PubMed Identifier
    21901677
    Citation
    Guenaga KF, Matos D, Wille-Jorgensen P. Mechanical bowel preparation for elective colorectal surgery. Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD001544. doi: 10.1002/14651858.CD001544.pub4.
    Results Reference
    background
    Citation
    Julious, S. A. (2005). Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Statistics, 4, 287-291.
    Results Reference
    background
    PubMed Identifier
    24817514
    Citation
    Nelson RL, Gladman E, Barbateskovic M. Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev. 2014 May 9;2014(5):CD001181. doi: 10.1002/14651858.CD001181.pub4.
    Results Reference
    background
    PubMed Identifier
    25598122
    Citation
    Rangel SJ, Islam S, St Peter SD, Goldin AB, Abdullah F, Downard CD, Saito JM, Blakely ML, Puligandla PS, Dasgupta R, Austin M, Chen LE, Renaud E, Arca MJ, Calkins CM. Prevention of infectious complications after elective colorectal surgery in children: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee comprehensive review. J Pediatr Surg. 2015 Jan;50(1):192-200. doi: 10.1016/j.jpedsurg.2014.11.028. Epub 2014 Nov 12.
    Results Reference
    background
    PubMed Identifier
    22244415
    Citation
    Serrurier K, Liu J, Breckler F, Khozeimeh N, Billmire D, Gingalewski C, Gollin G. A multicenter evaluation of the role of mechanical bowel preparation in pediatric colostomy takedown. J Pediatr Surg. 2012 Jan;47(1):190-3. doi: 10.1016/j.jpedsurg.2011.10.044.
    Results Reference
    background
    PubMed Identifier
    15082963
    Citation
    Smith RL, Bohl JK, McElearney ST, Friel CM, Barclay MM, Sawyer RG, Foley EF. Wound infection after elective colorectal resection. Ann Surg. 2004 May;239(5):599-605; discussion 605-7. doi: 10.1097/01.sla.0000124292.21605.99.
    Results Reference
    background
    PubMed Identifier
    27778060
    Citation
    Koullouros M, Khan N, Aly EH. The role of oral antibiotics prophylaxis in prevention of surgical site infection in colorectal surgery. Int J Colorectal Dis. 2017 Jan;32(1):1-18. doi: 10.1007/s00384-016-2662-y. Epub 2016 Oct 24.
    Results Reference
    background
    PubMed Identifier
    30343324
    Citation
    Janssen Lok M, Miyake H, O'Connell JS, Seo S, Pierro A. The value of mechanical bowel preparation prior to pediatric colorectal surgery: a systematic review and meta-analysis. Pediatr Surg Int. 2018 Dec;34(12):1305-1320. doi: 10.1007/s00383-018-4345-y. Epub 2018 Oct 20.
    Results Reference
    background
    PubMed Identifier
    30219553
    Citation
    Zwart K, Van Ginkel DJ, Hulsker CCC, Witvliet MJ, Van Herwaarden-Lindeboom MYA. Does Mechanical Bowel Preparation Reduce the Risk of Developing Infectious Complications in Pediatric Colorectal Surgery? A Systematic Review and Meta-Analysis. J Pediatr. 2018 Dec;203:288-293.e1. doi: 10.1016/j.jpeds.2018.07.057. Epub 2018 Sep 12.
    Results Reference
    background
    PubMed Identifier
    28433362
    Citation
    Ares GJ, Helenowski I, Hunter CJ, Madonna M, Reynolds M, Lautz T. Effect of preadmission bowel preparation on outcomes of elective colorectal procedures in young children. J Pediatr Surg. 2018 Apr;53(4):704-707. doi: 10.1016/j.jpedsurg.2017.03.060. Epub 2017 Mar 30.
    Results Reference
    background
    PubMed Identifier
    23961782
    Citation
    Billingham SA, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med Res Methodol. 2013 Aug 20;13:104. doi: 10.1186/1471-2288-13-104.
    Results Reference
    background
    PubMed Identifier
    18929686
    Citation
    Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.
    Results Reference
    background
    PubMed Identifier
    30646234
    Citation
    Toh JWT, Phan K, Hitos K, Pathma-Nathan N, El-Khoury T, Richardson AJ, Morgan G, Engel A, Ctercteko G. Association of Mechanical Bowel Preparation and Oral Antibiotics Before Elective Colorectal Surgery With Surgical Site Infection: A Network Meta-analysis. JAMA Netw Open. 2018 Oct 5;1(6):e183226. doi: 10.1001/jamanetworkopen.2018.3226.
    Results Reference
    background
    PubMed Identifier
    16291339
    Citation
    Nelson RM, Ross LF. In defense of a single standard of research risk for all children. J Pediatr. 2005 Nov;147(5):565-6. doi: 10.1016/j.jpeds.2005.08.051. No abstract available.
    Results Reference
    background

    Learn more about this trial

    Bowel Preparation in Elective Pediatric Colorectal Surgery

    We'll reach out to this number within 24 hrs